<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04982107</url>
  </required_header>
  <id_info>
    <org_study_id>ICL2020</org_study_id>
    <nct_id>NCT04982107</nct_id>
  </id_info>
  <brief_title>Quality of Vision in Implantable Collamer Lens (ICL)</brief_title>
  <official_title>Pupil Influence on the Quality of Vision in Implantable Collamer Lens (ICL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>He Eye Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>He Eye Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to observe the influence of pupil size upon visual outcome in&#xD;
      patients with Visian Implantable Collamer Lens(ICL) and toric-ICL implantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to observe the influence of pupil size upon the quality of vision&#xD;
      outcome in patients with Visian Implantable Collamer Lens(ICL) and toric-ICL implantation.&#xD;
      Pre-operation and 3-month post-operation pupil size, visual acuity, quality of vision will be&#xD;
      evaluated in patient that had ICL surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective Quality of vision</measure>
    <time_frame>Baseline (before surgery) and 3 month after surgery</time_frame>
    <description>Change in QoV questionnaire score after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pupil diameter pre-operation and post-operation</measure>
    <time_frame>Baseline (before surgery) and 3 month after surgery</time_frame>
    <description>Change in Pupil diameter after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Wave front aberrometry</measure>
    <time_frame>baseline and 3 month after surgery</time_frame>
    <description>Change in Wave front aberrometry after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Point Spread Function (PSF)</measure>
    <time_frame>baseline and 3 month after surgery</time_frame>
    <description>Change in Point Spread Function (PSF) after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strehl ratio</measure>
    <time_frame>Baseline and 3 month after surgery</time_frame>
    <description>Change in Pupil diameter after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Modulation transfer function (MTF)</measure>
    <time_frame>Baseline and 3 month after surgery</time_frame>
    <description>Change in Modulation transfer function after ICL surgery at 3-month testing will be compare with baseline measurements</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pupil Diameter</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Randomly choosen patients from the hospital records who had ICL surgery at He Eye Hospital,&#xD;
        Shenyang, China during September 2019 to September 2020. They must have signed informed&#xD;
        consent for their records to be used for education and research purposes before undergoing&#xD;
        ICL surgery for myopic correction.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Myopic eyes&#xD;
&#xD;
          -  Preoperative corneal endothelial cell count â‰¥2200/mm2&#xD;
&#xD;
          -  Preoperative central anterior chamber depth&gt; 2.80mm&#xD;
&#xD;
          -  Intraocular pressure within the normal range (10-21mmHg)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe dry eye&#xD;
&#xD;
          -  Cataract and glaucoma&#xD;
&#xD;
          -  Patients with uveitis&#xD;
&#xD;
          -  Retinal detachment&#xD;
&#xD;
          -  Patients with autoimmune diseases&#xD;
&#xD;
          -  Patients with systemic diseases such as diabetes and hypertension&#xD;
&#xD;
          -  Patients with mental or cognitive abnormalities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei He</last_name>
    <role>Study Chair</role>
    <affiliation>He Eye Specialist Hospital, Shenyang.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qing Zhang</last_name>
    <phone>+8618340838521</phone>
    <email>zhangqing_cn_2020@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emmanuel E Pazo</last_name>
    <phone>+8618612782131</phone>
    <email>ericpazo@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>He Eye Specialist Hospital, Shenyang.</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110141</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qing Zhang, M.D.</last_name>
      <phone>+8618340838521</phone>
      <email>zhangqing_cn_2020@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Emmanuel E Pazo, M.D., Ph.D.</last_name>
      <phone>+8618612782131</phone>
      <email>ericpazo@outlook.com</email>
    </contact_backup>
    <investigator>
      <last_name>Qing Zhang, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ICL</keyword>
  <keyword>QoV</keyword>
  <keyword>Visual acuity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

